TY - JOUR
T1 - preventing and diagnosing HIV-related comorbidities in adolescents
AU - Yusuf, Hasiya Eihuri
AU - Griffith, David
AU - Agwu, Allison Lorna
PY - 2022/10/1
Y1 - 2022/10/1
N2 - Adolescents with HIV are growing into adulthood and are at risk for comorbidities. Comorbidities in adolescents often go unrecognized, increasing morbidity and mortality, and contributing to poorer outcomes for youth with HIV. Youth with perinatally and nonperinatally acquired HIV are at risk of developing HIV-associated and non-HIV comorbidities, including cardiovascular diseases, diabetes, mental health disorders, renal diseases, and bone disorders. Youth with HIV are also at risk for altered fat distribution and weight gain associated with certain classes of antiretroviral therapy. Sexually transmitted infections from inconsistent condom use pose a sexual health challenge for youth with HIV. Prompt interventions through comprehensive history taking, physical exams, regular screening, and prevention and treatment of clinically evident comorbid conditions are needed to prevent progression and complications.
AB - Adolescents with HIV are growing into adulthood and are at risk for comorbidities. Comorbidities in adolescents often go unrecognized, increasing morbidity and mortality, and contributing to poorer outcomes for youth with HIV. Youth with perinatally and nonperinatally acquired HIV are at risk of developing HIV-associated and non-HIV comorbidities, including cardiovascular diseases, diabetes, mental health disorders, renal diseases, and bone disorders. Youth with HIV are also at risk for altered fat distribution and weight gain associated with certain classes of antiretroviral therapy. Sexually transmitted infections from inconsistent condom use pose a sexual health challenge for youth with HIV. Prompt interventions through comprehensive history taking, physical exams, regular screening, and prevention and treatment of clinically evident comorbid conditions are needed to prevent progression and complications.
UR - http://www.scopus.com/inward/record.url?scp=85141894289&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141894289&partnerID=8YFLogxK
M3 - Article
C2 - 36347060
AN - SCOPUS:85141894289
SN - 2161-5853
VL - 30
SP - 537
EP - 544
JO - Topics in antiviral medicine
JF - Topics in antiviral medicine
IS - 4
ER -